New immunotherapies are seldom developed for childhood cancer

Apr 10, 2013

More often than not, cancer immunotherapies that work in adults are used in modified ways in children. Seldom are new therapies developed just for children, primarily because of the small number of pediatric patients relative to the adult cancer patient population. In 2013 there will be an estimated 11,630 cases of cancer diagnosed in children 14 and younger compared to over 1.6 million cases diagnosed in adults.

Suicidal ideation significantly higher among childhood cancer survivors

New test identifies high-risk childhood brain tumours, improving treatment decisions

Melanoma risk doubles among childhood cancer survivors

UC Irvine-led study finds possible links between PFAS exposure and childhood cancers

Researchers Find Inherited Genetic Condition Raises Risk of Developing Two Rare Pediatric Cancers

Parental Alcohol Use Linked To Increased Cancer Risk In Children, Texas A&M Researchers Find

Simple blood test could lead to smarter, kinder treatments for childhood cancers

Agricultural pesticide exposure linked to childhood cancers, study says

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

Childhood Cancer Treatments May Increase Diabetes Risk

Recent Posts